The suPAR level is associated with presence, severity and progression of disease, and in unselected patients, suPAR is one of the strongest prognostic biomarkers available to date. The suPAR-level is, across diseases, directly linked to morbidity and mortality and therefore can be used to discriminate between non-survivors and survivors. Please find more information here regarding suPAR and its application in the following disease areas; Cancer . Cardiovascular disease COVID-19 . Emergency department Endocrinology . Gastroenterology . General population . Infectious diseases . Intensive care . Nephrology . Neurology . Pulmonary disease . Surgery .